search
Back to results

The Whole Day Matters After Stroke (BIG-STEPS) (BIG-STEPS)

Primary Purpose

Stroke

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS) intervention
Sponsored by
University of Alberta
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke, Movement Behaviors, Leukoaraiosis, Whole Day

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Within 7 days of ischemic stroke onset Aged ≥ 18 years Medically stable as deemed by physicians Able to walk at least 5 meters with/without gait aid Ongoing walking goals (walk speed <1.0 meter/sec) Exclusion Criteria: Have another condition such as multiple sclerosis or Parkinson's disease, or active cancer Uncontrolled high blood pressure Unstable cardiovascular condition Unable to understand or follow instructions.

Sites / Locations

  • University of Alberta HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS)

Usual care:

Arm Description

Additional to usual care, the experimental arm will undergo a theory-based behaviour change intervention to improve stepping time relative to reducing sedentary behaviour.

The control arm program will consist of usual inpatient care including therapeutic mobilization by the physical therapy team and general mobilization, as tolerated, by the nursing team.

Outcomes

Primary Outcome Measures

Change from Baseline modified Rankin Scale (mRS) at 6 and 12 weeks
Measure of global disability using the mRS score [grade 0-2 vs ≥3]
Change from Baseline Timed-Up and Go (TUG) test at 6 and 12 weeks
Functional mobility will be assessed using the TUG test

Secondary Outcome Measures

Change from Baseline ActivPAL-derived movement behaviors at 6 and 12 weeks
Whole-day movement behaviours (time spent stepping, sedentary, sleeping, number of steps, and sit-to-stand transitions)
Change from Baseline 10-meter walk test at 6 and 12 weeks
Measure of gait speed
Change from Baseline 6-minute walk test at 6 and 12 weeks
6-minute walk test of endurance
Change from Baseline Montreal Cognitive Assessment (MoCA) at 6 and 12 weeks
Montreal Cognitive Assessment (MoCA) test of cognition
Change from Baseline EuroQol (EQ)-5D at 6 and 12 weeks
EQ-5D to assess quality of life
Change from Baseline National Institute of Health Stroke Scale (NIHSS) at 6 and 12 weeks
NIHSS to classify stroke severity
Leukoraiosis staging/severity at Baseline
White matter disease on imaging

Full Information

First Posted
February 10, 2023
Last Updated
July 11, 2023
Sponsor
University of Alberta
search

1. Study Identification

Unique Protocol Identification Number
NCT05753761
Brief Title
The Whole Day Matters After Stroke (BIG-STEPS)
Acronym
BIG-STEPS
Official Title
The Whole Day Matters After Stroke: Moving Towards Precision Rehabilitation Guided by Behavioural and Imaging Markers
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 10, 2023 (Actual)
Primary Completion Date
March 2025 (Anticipated)
Study Completion Date
December 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Alberta

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Goal of research program: To understand person-specific factors, such as imaging markers and activity patterns early after stroke, that may guide precision rehabilitation to optimize function and improve recovery. Objectives: Test the effect of reducing sedentary behaviour early after stroke on functional mobility and global disability outcomes. Determine the impact of neuroimaging biomarkers (e.g. leukoaraiosis) on response to rehabilitation. Explore the predictive value of accelerometry as an adjunct to the subjective modified Rankin Scale (mRS) to assess functional disability after stroke. Experimental approach/Research Plan/Use of Funds: The investigators aim to recruit 50 participants within 1 week of ischemic stroke onset, aged ≥ 18 years, medically stable as deemed by their physicians, able to walk at least 5 meters with/without gait aid and with ongoing walking or balance goals. Demographic and stroke characteristics, including stroke risk factors, infarct location and volume, leukoaraiosis on routine MRI, and acute stroke treatments (e.g., thrombectomy) will be determined and documented. A battery of impairment, psychosocial, and functional measures, including the mRS and Timed-Up and Go test (primary outcomes) will be completed. Subsequently, participants will be set up to wear activPAL accelerometer, validated in stroke, for 1 week. Following randomization, a sedentary behaviour change intervention will span 6 weeks, with final follow-up assessments at 90 days.
Detailed Description
Background Prolonged sedentary behaviour is associated with worse functional outcomes poststroke. The effect of reducing sedentary behaviour early after stroke remains unknown. Leukoaraiosis or cerebral white matter disease, recognizable on magnetic resonance imaging (MRI) as areas of hyperintensities, has gained significance as a potential moderator of stroke recovery. No specific rehabilitation intervention has been developed for survivors of stroke with leukoaraiosis. The goals of this research project are to: Test the effect of reducing sedentary behaviour early after stroke on functional mobility and global disability outcomes. Determine the impact of leukoaraiosis on response to poststroke rehabilitation. Explore the associations of accelerometry metrics with functional mobility and global disability outcomes poststroke. Methods The investigators aim to recruit 50 participants, within 7 days of ischemic stroke onset, aged ≥ 18 years, medically stable as deemed by physicians, able to walk at least 5 meters with/without gait aid, and ongoing walking goals (walk speed <1.0 meter/second). Demographic and stroke characteristics, including stroke risk factors, infarct location and volume, leukoaraiosis on MRI, and acute stroke treatments (e.g. thrombectomy) will be determined and documented. Subsequently, participants will be set up to wear activPAL accelerometer, validated in stroke,5 for one week. Following randomization, a behaviour change intervention will span 6 weeks with final follow-up assessments at 90 days. Primary outcomes: modified Rankin Scale and Timed-Up and Go (TUG) score. Plan for Data Analysis Compositional data analysis and generalized estimating equations with R software will be used to model the effect of reducing sedentary behaviour and impact of leukoaraiosis on response to rehabilitation. The correlation, responsiveness, and predictive value of the activPAL outcomes as adjunct to the mRS and TUG measures will be evaluated using machine learning, logistic regression, and receiver operating curves. Significance and Expected Results The first 90 days after stroke represents a critical window of neuroplasticity. Frequent interruptions in sedentary behaviour, using a whole-day approach, may improve function and recovery, especially for poor responders. If the investigators find this rehabilitation approach to be effective for survivors of stroke with leukoaraiosis, then it could be useful for improving decision-making. Accelerometry as an adjunct to the MRS will increase the granularity of outcome measurement poststroke.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Stroke, Movement Behaviors, Leukoaraiosis, Whole Day

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS)
Arm Type
Experimental
Arm Description
Additional to usual care, the experimental arm will undergo a theory-based behaviour change intervention to improve stepping time relative to reducing sedentary behaviour.
Arm Title
Usual care:
Arm Type
Active Comparator
Arm Description
The control arm program will consist of usual inpatient care including therapeutic mobilization by the physical therapy team and general mobilization, as tolerated, by the nursing team.
Intervention Type
Behavioral
Intervention Name(s)
Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS) intervention
Intervention Description
Using baseline accelerometry data, personalized goals of replacing sedentary time with stepping time will be developed.
Primary Outcome Measure Information:
Title
Change from Baseline modified Rankin Scale (mRS) at 6 and 12 weeks
Description
Measure of global disability using the mRS score [grade 0-2 vs ≥3]
Time Frame
6 and 12 weeks
Title
Change from Baseline Timed-Up and Go (TUG) test at 6 and 12 weeks
Description
Functional mobility will be assessed using the TUG test
Time Frame
6 and 12 weeks
Secondary Outcome Measure Information:
Title
Change from Baseline ActivPAL-derived movement behaviors at 6 and 12 weeks
Description
Whole-day movement behaviours (time spent stepping, sedentary, sleeping, number of steps, and sit-to-stand transitions)
Time Frame
6 and 12 weeks
Title
Change from Baseline 10-meter walk test at 6 and 12 weeks
Description
Measure of gait speed
Time Frame
6 and 12 weeks
Title
Change from Baseline 6-minute walk test at 6 and 12 weeks
Description
6-minute walk test of endurance
Time Frame
6 and 12 weeks
Title
Change from Baseline Montreal Cognitive Assessment (MoCA) at 6 and 12 weeks
Description
Montreal Cognitive Assessment (MoCA) test of cognition
Time Frame
6 and 12 weeks
Title
Change from Baseline EuroQol (EQ)-5D at 6 and 12 weeks
Description
EQ-5D to assess quality of life
Time Frame
6 and 12 weeks
Title
Change from Baseline National Institute of Health Stroke Scale (NIHSS) at 6 and 12 weeks
Description
NIHSS to classify stroke severity
Time Frame
6 and 12 weeks
Title
Leukoraiosis staging/severity at Baseline
Description
White matter disease on imaging
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Within 7 days of ischemic stroke onset Aged ≥ 18 years Medically stable as deemed by physicians Able to walk at least 5 meters with/without gait aid Ongoing walking goals (walk speed <1.0 meter/sec) Exclusion Criteria: Have another condition such as multiple sclerosis or Parkinson's disease, or active cancer Uncontrolled high blood pressure Unstable cardiovascular condition Unable to understand or follow instructions.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Victor Ezeugwu, PhD
Phone
7804925108
Email
ezeugwu@ualberta.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Victor Ezeugwu, PhD
Organizational Affiliation
University of Alberta
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Alberta Hospital
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 2B7
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Victor Ezeugwu, PT, PhD
Phone
7804925108
Email
ezeugwu@ualberta.ca
First Name & Middle Initial & Last Name & Degree
Brian Buck, MD
First Name & Middle Initial & Last Name & Degree
Glen Jickling, MD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Study team will have access to individual participant data.

Learn more about this trial

The Whole Day Matters After Stroke (BIG-STEPS)

We'll reach out to this number within 24 hrs